News
As new treatments for systemic lupus erythematosus and lupus nephritis enter the armamentarium, revitalizing the management ...
You might associate autoimmune conditions with symptoms like skin disease, chronic pain, and fatigue. A less-discussed ...
The U.S. Food & Drug Administration (FDA) has granted approval for a new subcutaneous autoinjector formulation of belimumab (Benlysta®) treatment for children ages five years and older with active ...
Systemic lupus erythematosus articles from across Nature Portfolio Systemic lupus erythematosus is a potentially fatal autoimmune disease that is characterized by wide-spread inflammation and ...
Current treatment options for systemic lupus erythematosus (SLE) consists of glucocorticoids, antimalarials, immunosuppressives, and a few biologics, approved or of 'off-label'. Through judicious ...
D-dimer assays are used as a tool to rule out thrombosis in symptomatic patients with lupus, but could they also be used to initiate preventive anticoagulation in asymptomatic patients?
A lupus diagnosis can profoundly affect many aspects of a man’s life, from sense of identity and mental health to the way one engages with loved ones and the broader community. While lupus is often ...
The FDA has approved Benlysta for SC administration using an autoinjector in patients 5 years of age and older with active LN.
A nova explosion has been discovered shining in the constellation Lupus. Here’s how to spot it before it fades.
A rare and temporary "new star" has burst into view in the night sky, and it's now visible to the naked eye from parts of North America. The stellar explosion, now officially designated V462 Lupi ...
Full results from the first phase 3 trial of UCB and Biogen's anti-CD40L antibody dapirolizumab pegol (DZP) in systemic lupus erythematosus (SLE) have been revealed, and have not disappointed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results